Immunotherapy: Targeting MDSCs with LXR agonists

Immunotherapy: Targeting MDSCs with LXR agonistsImmunotherapy: Targeting MDSCs with LXR agonists, Published online: 31 January 2018; doi:10.1038/nrclinonc.2018.17Immunotherapy: Targeting MDSCs with LXR agonists

https://www.nature.com/articles/nrclinonc.2018.17

Source: Nature Clinical Practice Oncology - January 31, 2018 Category: Cancer & Oncology Authors: David Killock Source Type: research

More News: Cancer & Oncology | Immunotherapy